Fellowship Award
Groundbreaking research into diabetic retinopathy and telemedicine wins fellowship
Colin Kerr
Published: Tuesday, July 9, 2019
[caption id="attachment_15737" align="alignleft" width="1024"]
From left: Prof Peter Wiedemann (ICO President), Neeru Gupta (ICO Vice President),
Dr Matias Iglicki, Prof Berthold Seitz (ICO Director of Fellowships)[/caption] A panel of leading experts has selected groundbreaking research into diabetic retinopathy and telemedicine as the winner of this year’s International Council of Ophthalmology (ICO) and Allergan Fellowship. Dr Matias Iglicki from the University of Buenos Aires in Argentina is the second recipient of the ICO-Allergan Fellowship Award. The award of a $50,000 grant, announced at the 2019 European Society of Ophthalmology meeting in Nice, France, will enable Dr Iglicki to continue his research into diabetic retinopathy and telemedicine, which he has been working on since 2004. https://www.allergan.ie/en-ie/home
From left: Prof Peter Wiedemann (ICO President), Neeru Gupta (ICO Vice President),Dr Matias Iglicki, Prof Berthold Seitz (ICO Director of Fellowships)[/caption] A panel of leading experts has selected groundbreaking research into diabetic retinopathy and telemedicine as the winner of this year’s International Council of Ophthalmology (ICO) and Allergan Fellowship. Dr Matias Iglicki from the University of Buenos Aires in Argentina is the second recipient of the ICO-Allergan Fellowship Award. The award of a $50,000 grant, announced at the 2019 European Society of Ophthalmology meeting in Nice, France, will enable Dr Iglicki to continue his research into diabetic retinopathy and telemedicine, which he has been working on since 2004. https://www.allergan.ie/en-ie/home
Tags: allergan, diabetic retinopathy, telemedicine
Latest Articles
ESCRS Today 2025: Happy Anniversaries!
ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.
ESCRS Today 2025: A Congress for Everyone
From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.